Replay available

Delcath Systems, Inc. (DCTH) Q1 2025 Earnings Call

Delcath Systems, Inc. (NASDAQ: DCTH) Q1 2025 earnings conference call, held 2025-05-08. Replay captured from the company's public earnings webcast.

Thu, May 8, 2025 at 8:30 AMendedReplay
Delcath Systems, Inc. (DCTH) Q1 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

David Hoffman

General Counsel, DELCAS Systems

Gerard Michel

Chief Executive Officer, DELCAS Systems

Sandra Pinnell

Chief Financial Officer, DELCAS Systems

Kevin Muir

General Manager, Interventional Oncology, DELCAS Systems

Vojo Vukovic

Chief Medical Officer, DELCAS Systems

Chase Knickerbocker

Analyst, Craig Hallum Capital Group

Maria Turbolt

Analyst, BTIG

Hale Jen

Analyst, LeBlanc & Company

Bill Morgan

Analyst, Clear Street

Sudan Loganathan

Analyst, Stephens Inc.

Replay transcript excerpt

Good day and welcome to the Dell Curve Systems first quarter 2025 earnings call. All participants are in listen-only mode. There will be an opportunity to ask questions at the end of the formal presentation. If anyone should require operator assistance during the conference, please press star and then zero on your telephone keypad. Please note that this event is being recorded. I'd now like to turn the conference over to Mr. David Hoffman, DELCAS General Counsel. Go ahead, sir. Thank you. And once again, welcome to DELCAS Systems' first quarter 2025 Earnings and Business Highlights Call. With me on the call are Gerard Michel, the Chief Executive Officer, Sandra Pinnell, Chief Financial Officer, Kevin Muir, General Manager, Interventional Oncology, Vojo Vukovic, Chief Medical Officer, and Martha Rook, Chief Operating Officer. I'd like to begin the call by reading the Safe Harbor Statement. This statement is made pursuant to the Safe Harbor for forward-looking statements described in the Private Securities Litigation Reform Act of 1995. All statements made on this call, with the exception of historical facts, may be considered forward-looking statements within the meaning of Section 27 of the Securities Act of 1933 and Section 21 of the Securities Exchange Act of 1934. Although the company believes that expectations and assumptions reflected in these forward-looking statements are reasonable, it makes no assurance that such expectations will prove to have been correct. Actual results may differ in a material manner from those expressed or implied in forward-looking statements due to various risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those expressed or implied in the forward-looking statemen...

More from Delcath Systems, Inc.